Search

everythinglearnresearchcommunity

for

Search:↓

Early-onset hair loss in Egyptian males is linked to genetics, hormones, and lifestyle factors like smoking and diet.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Acanthosis nigricans in teenage girls with PCOS is a sign of obesity, not insulin resistance or glucose intolerance.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Women with PCOS have hormonal imbalances and increased central obesity, highlighting the need for early detection and management.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Acne is an important sign of androgen excess disorders in women.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

Women with acne often have higher levels of male hormones and are more likely to be overweight, both of which can make acne worse.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Combined finasteride and spironolactone therapy significantly improves quality of life in women with PCOS.